Mersana Therapeutics
MRSN
MRSN
120 hedge funds and large institutions have $230M invested in Mersana Therapeutics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 122 → 120 (-2)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
56% less capital invested
Capital invested by funds: $526M → $230M (-$297M)
Holders
120
Holding in Top 10
1
Calls
$1.5M
Puts
$1.26M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$3.96M | |
| 3 | +$1.15M | |
| 4 |
Two Sigma Advisers
New York
|
+$1.13M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.1M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$5.66M | |
| 3 | -$3.59M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.95M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.6M |